Article
Overexpression of CDKN2B is involved in poor gastric cancer prognosis
11 Jul 2019
Abstract excerpt
Abstract The objective of this investigation is to elucidate the clinical significance of cyclin‐dependent kinase inhibitor 2B (CDKN2B) expression regarding gastric cancer (GC), as well as to detect the involvement of CDKN2B expression in the clinicopathological indexes and prognosis of GC. Immunohistochemical analysis was used for identification of CDKN2B expression in GC specimens. Chi‐square (χ2) test was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
